IκB Kinase 2 Regulates TPL-2 Activation of Extracellular Signal-Regulated Kinases 1 and 2 by Direct Phosphorylation of TPL-2 Serine 400

REFERENCES

• Aoki M, et al. 1993. The human cot proto-oncogene encodes two protein serine/threonine kinases with different transforming activities by alternative initiation of translation. J. Biol. Chem. 268:22723–22732.
   PubMed Web of Science ®Google Scholar
• Beinke S, Belich MP, Ley SC. 2002. The death domain of NF-κB1 p105 is essential for signal-induced p105 proteolysis. J. Biol. Chem. 277:24162–24168.
   PubMedGoogle Scholar
• Beinke S, et al. 2003. NF-κB p105 negatively regulates TPL-2 MEK kinase activity. Mol. Cell. Biol. 23:4739–4752.
   PubMedGoogle Scholar
• Beinke S, et al. 2004. Lipopolysaccharide activation of the TPL-2/MEK/extracellular signal-regulated kinase mitogen-activated protein kinase cascade is regulated by IκB kinase-induced proteolysis of NF-κB1 p105. Mol. Cell. Biol. 24:9658–9667.
   PubMedGoogle Scholar
• Belich MP, Salmeron A, Johnston LH, Ley SC. 1999. TPL-2 kinase regulates the proteolysis of the NF-κB inhibitory protein NF-κB1 p105. Nature 397:363–368.
   PubMedGoogle Scholar
• Cho J, Melnick M, Solidakis GP, Tsichlis PN. 2005. Tpl2 (tumor progression locus 2) phosphorylation at Thr290 is induced by lipopolysaccharide via an IκB kinase-β-dependent pathway and is required for Tpl2 activation by external signals. J. Biol. Chem. 280:20442–20448.
   PubMedGoogle Scholar
• Clark K, et al. 2011. Novel cross-talk within the IKK family controls innate immunity. Biochem. J. 434:93–104.
   PubMed Web of Science ®Google Scholar
• Dumitru CD, et al. 2000. TNFα induction by LPS is regulated post-transcriptionally via a TPL2/ERK-dependent pathway. Cell 103:1071–1083.
   PubMed Web of Science ®Google Scholar
• Eliopoulos AG, Wang C-C, Dumitru CD, Tsichlis PN. 2003. TPL-2 transduces CD40 and TNF signals that activate ERK and regulates IgE induction by CD40. EMBO J. 22:3855–3864.
   PubMed Web of Science ®Google Scholar
• Gantke T, Sriskantharajah S, Sadowski M, Ley SC. 2012. IκB kinase regulation of the TPL-2/ERK MAPK pathway. Immunol. Rev. 246:168–182.
   PubMed Web of Science ®Google Scholar
• Handoyo H, et al. 2009. IRAK1-independent pathways required for the interleukin 1-stimulated activation of the TPL-2 catalytic subunit and its dissociation from ABIN-2. Biochem. J. 424:109–118.
   PubMedGoogle Scholar
• Hayden MS, Ghosh S. 2008. Shared principles in NF-κB signaling. Cell 132:344–362.
   PubMed Web of Science ®Google Scholar
• Hutti JE, et al. 2004. A rapid method for determining protein kinase phosphorylation specificity. Nat. Methods 1:27–29.
   PubMed Web of Science ®Google Scholar
• Jia Y, et al. 2005. Purification and kinetic characterization of recombinant human mitogen-activated protein kinase kinase kinase COT and the complexes with its cellular partner NF-κB1 p105. Arch. Biochem. Biophys. 441:64–74.
   PubMed Web of Science ®Google Scholar
• Kaiser F, et al. 2009. TPL-2 negatively regulates interferon-β production in macrophages and myeloid dendritic cells. J. Exp. Med. 206:1863–1871.
   PubMed Web of Science ®Google Scholar
• Kanters E, et al. 2003. Inhibition of NF-κB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. J. Clin. Invest. 112:1176–1185.
   PubMed Web of Science ®Google Scholar
• Karin M, Ben-Neriah Y. 2000. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18:621–663.
   PubMed Web of Science ®Google Scholar
• Karin M, Gallagher E. 2009. TNFR signaling: ubiquitin-conjugated TRAFfic signals control stop-and-go for MAPK signaling complexes. Immunol. Rev. 228:225–240.
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11:373–384.
   PubMed Web of Science ®Google Scholar
• König R, et al. 2007. A probability-based approach for the analysis of large-scale RNAi screens. Nat. Methods 4:847–849.
   PubMed Web of Science ®Google Scholar
• Kontoyiannis D, et al. 2002. Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn's-like inflammatory bowel disease. J. Exp. Med. 196:1563–1574.
   PubMed Web of Science ®Google Scholar
• Lang V, et al. 2003. βTrCP-mediated proteolysis of NF-κB1 p105 requires phosphorylation of p105 serines 927 and 932. Mol. Cell. Biol. 23:402–413.
   PubMedGoogle Scholar
• Lang V, et al. 2004. ABIN-2 forms a ternary complex with TPL-2 and NF-κB1 p105 and is essential for TPL-2 protein stability. Mol. Cell. Biol. 24:5235–5248.
   PubMedGoogle Scholar
• Li X, Commane M, Jiang Z, Stark GR. 2001. IL-1-induced NF-kB and c-Jun N-terminal kinase (JNK) activation at IL-1 receptor-associated kinase (IRAK). Proc. Natl. Acad. Sci. U. S. A. 98:4461–4465.
   PubMedGoogle Scholar
• Lin X, Cunningham ET, Mu Y, Geleziunas R, Greene WC. 1999. The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-κB acting through the NF-κB-inducing kinase and IκB kinases. Immunity 10:271–280.
   PubMed Web of Science ®Google Scholar
• Mielke LA, et al. 2009. Tumor progression locus 2 (Map3k8) is critical for host defense against Listeria monocytogenes and IL-1 production. J. Immunol. 183:7984–7993.
   PubMed Web of Science ®Google Scholar
• Morita K-I, et al. 2001. Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress. EMBO J. 20:6028–6036.
   PubMed Web of Science ®Google Scholar
• Papoutsopoulou S, et al. 2006. ABIN-2 is required for optimal activation of the TPL-2 / ERK MAP kinase pathway in innate immune responses. Nat. Immunol. 7:606–615.
   PubMedGoogle Scholar
• Robinson MJ, Beinke S, Kouroumalis A, Tsichlis PN, Ley SC. 2007. Phosphorylation of TPL-2 on serine 400 is essential for lipopolysaccharide activation of extracellular signal-regulated kinase in macrophages. Mol. Cell. Biol. 27:7355–7364.
   PubMedGoogle Scholar
• Salmeron A, et al. 2001. Direct phosphorylation of NF-κB p105 by the IκB kinase complex on serine 927 is essential for signal-induced p105 proteolysis. J. Biol. Chem. 276:22215–22222.
   PubMed Web of Science ®Google Scholar
• Sha WC, Lious H-C, Tuomanen EI, Baltimore D. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80:321–330.
   PubMed Web of Science ®Google Scholar
• Smale ST. 2010. Selective transcription in response to an inflammatory stimulus. Cell 140:833–844.
   PubMed Web of Science ®Google Scholar
• Sriskantharajah S, et al. 2009. Proteolysis of NF-κB1 p105 is essential for T cell antigen receptor-induced proliferation. Nat. Immunol. 10:38–47.
   PubMedGoogle Scholar
• Symons A, Beinke S, Ley SC. 2006. MAP kinase kinase kinases and innate immunity. Trends Immunol. 27:40–48.
   PubMed Web of Science ®Google Scholar
• Warren MK, Vogel SN. 1985. Bone marrow-derived macrophages: development and regulation of differentiation markers by colony-stimulating factor and interferons. J. Immunol. 134:982–989.
   PubMedGoogle Scholar
• Waterfield M, Jin W, Reiley W, Zhang MY, Sun S-C. 2004. IKKβ is an essential component of the TPL-2 signaling pathway. Mol. Cell. Biol. 24:6040–6048.
   PubMedGoogle Scholar
• Waterfield MR, Zhang M, Norman LP, Sun S-C. 2003. NF-κB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the TPL-2 kinase. Mol. Cell 11:685–694.
   PubMed Web of Science ®Google Scholar
• Yang HT, et al. 2012. Coordinate regulation of TPL-2 and NF-κB signaling in macrophages by NF-kB1 p105. Mol. Cell. Biol. 32:3438–3451.
   PubMedGoogle Scholar
• Yang HT, et al. 2011. NF-κB1 inhibits TLR-induced IFN-β production in macrophages through TPL-2-dependent ERK activation. J. Immunol. 186:1989–1996.
   PubMedGoogle Scholar